Intended for healthcare professionals

Feature Formula Milk

Overdiagnosis and industry influence: how cow’s milk protein allergy is extending the reach of infant formula manufacturers

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5056 (Published 05 December 2018) Cite this as: BMJ 2018;363:k5056

Read all The BMJ's investigations

Re: Overdiagnosis and industry influence: how cow’s milk protein allergy is extending the reach of infant formula manufacturers

As a GP many of the parents I see with concerns have been sent and 'informed' by their health visitors.

Who educates the health visitors on their knowledge, application and impact potential? They are likely to be acting on 'the national guidance', unaware of its pitfalls and the subsequent compromised position the GP who next sees this parent and child finds themselves in.

As one of the GPs quoted in the article put it, “Virtually every single infant could potentially be diagnosed using these symptoms.” I couldn't agree more.

We need to include the whole of the community care system who deal with infants if we want to make some impact on this new 'health concern for parents', this pharmaceutical epidemic, this unnecessary un-affordable drain on NHS funds.

Competing interests: No competing interests

17 December 2018
Dukes Nathalie
GP
Grimsby and Scunthorpe